CP and Wilson disease: First, although the majority (85%) of WD patients with neurological manifestations have a serum ceruloplasmin level of < 0.2 g/L (usually < 0.01-0.1 g/L, or zero sometimes), up to 40% of the patients with active hepatic involvement (including those with ALF) have serum ceruloplasmin levels within the normal range.